Statistics from Altmetric.com
Is drug therapy effective for reducing clozapine induced hypersalivation?
Measurement of salivation, measured as cure, no change, endpoint salivation score or change in salivation scores. Secondary outcomes included assessment of global state, service use, mental state, general functioning, behaviour, adverse effects, engagement, quality of life, satisfaction and costs.
Systematic review with meta-analysis.
Cochrane Schizophrenia Group Trials Register; search to March 2007.
Study selection and analysis:
Six reviewers independently selected and appraised RCTs comparing treatment with any pharmacological intervention versus placebo or no treatment for any condition in populations, regardless of age and gender, all of whom had identified clozapine induced hypersalivation (identified by self, carer or clinician). Disagreements were resolved by consensus (see online notes for further methodological details). Reviewers performed several meta-analyses, pooling dichotomous results and continuous data for each outcome and comparator. Only some of these results are presented here.
Source of funding: No external sources of funding received.
▸ Additional notes and a reference list are published online only at http://ebmh.bmj.com/content/vol12/issue1
Competing interests: GR has received research funding from Novartis and Merck Germany.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.